ask="5.55"
ask_size="2700"
average_daily_volume="1414120"
bid="4.00"
bid_size="200"
book_value="-0.08"
change="+0.07"
change_from_200_day_moving_average="0.14"
change_from_50_day_moving_average="0.29"
change_from_52_week_high="-2.38"
change_From_52_week_low="1.43"
change_in_percent="+1.31%"
close="5.42"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.52"
ebitda="-121.76M"
eps_estimate_current_year="-0.67"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="72994000"
high="5.46"
high_52_weeks="7.80"
last_trade_date="3/10/2017"
last_trade_price="5.42"
last_trade_size="61341"
last_trade_time="4:00pm"
low="5.25"
low_52_weeks="3.99"
market_capitalization="583.56M"
moving_average_200_day="5.28"
moving_average_50_day="5.13"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.00"
open="5.41"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+2.70%"
percent_change_from_50_day_moving_average="+5.62%"
percent_change_from_52_week_high="-30.51%"
percent_change_from_52_week_low="+35.84%"
previous_close="5.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="18.01"
revenue="31.98M"
shares_outstanding="107667000"
short_ratio="14.93"
stock_exchange="NCM"
symbol="KERX"
volume="1142840"
weeks_range_52="3.99 - 7.80"
